Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency

Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She also worries that California legislators may unwittingly jeopardize future innovation and harm patients in the long run, through Senate Bill 17. The proposed legislation purports to address healthcare spending, but will doing nothing to address prices that consumers actually pay for medicine.

To learn more about the factors that impact the cost of prescription biopharmaceuticals, go to www.drugcostfacts.org.

Filed under: Inside BIO Industry Analysis, , , , ,